Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 12/3/2020NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance Q...
  • 12/3/2020CDE Issues the Technical Guidelines for Clinical Communications Before...
  • 12/1/2020NMPA and ANVISA Sign MoU on Cooperation (Free)
  • 11/29/2020CDE Issues the Technical Guidelines for Clinical Trial Endpoints for L...
  • 11/29/2020CDE Issues the Guidelines for Use of GnRH Stimulants in Clinical Trial...
  • 11/27/2020CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
  • 11/26/2020NMPA and Chinese Customs Announce Addition of Two Drug Import Destinat...
  • 11/26/2020China Issues the Working Plan for Innovative Development of Drug and M...
  • 11/25/2020CDE Issues the CDE Guidelines for Management of Supplemental Informati...
  • 11/23/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...
  • 11/23/2020CDE Solicits Comments on Two Draft Documents for Phase I Clinical Tria...
  • 11/19/2020CDE Issues the Technical Guidelines for Conditional Approval of Drugs ...
  • 11/19/2020CDE Issues the List of Urgently-needed New Drugs Marketed Overseas (Ba...
  • 11/17/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 11/12/2020NMPA Solicits Comments on Draft Provisions for Supervision and Adminis...
  • 11/10/2020CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
  • 11/5/2020NHC Solicits Comments on Guidelines for Overall Clinical Evaluation of...
  • 11/4/2020CDE Issues the Technical Guidelines for All Stages of Pharmaceutical S...
  • 10/29/2020CDE Solicits Comments on the Draft Procedures and Requirements for Inc...
  • 10/29/2020CDE Publicizes the List of Urgently-needed New Drugs Marketed Overseas...
  • 10/27/2020NMPA Announces Designation of 100 National Drug Abuse Surveillance Pos...
  • 10/27/2020CDE Seeks Comments on the Draft Measures on Transparency of Drug Evalu...
  • 10/23/2020CDE Issues the General Requirements for Oral Tablet Scoring Design and...
  • 10/22/2020COHGRM Issues Notice on Further Optimizing the Administrative Approval...
  • 10/22/2020CDE Issues the Two Generic Drug Research Guidelines for Doxorubicin an...
  • 10/22/2020CDE Issues the Guidance for Acceptance and Evaluation of TCMs
  • 10/21/2020CDE Issues the Two Guidelines on Package Integrity Testing and Plastic...
  • 10/21/2020CDE Issues Notice on Supplemental Information for GQCE Applications fo...
  • 10/21/2020CDE Seeks Comments on Draft ICH Guideline Q2D(R2)
  • 10/18/2020CDE Issues the Requirements for Application Dossiers of Generic Chemic...
  • Page:1/9 Total number of articles:247: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group